(Q30234829)

English

Prevalence of clinically significant liver disease within the general population, as defined by non-invasive markers of liver fibrosis: a systematic review.

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28404158%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

systematic review

1 reference

based on heuristic

inferred from title

Prevalence of clinically significant liver disease within the general population, as defined by non-invasive markers of liver fibrosis: a systematic review (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28404158%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

systematic review

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Timothy R. Card

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28404158%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28404158%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

object named as

Rebecca Harris

1

1 reference

ORCID Public Data File 2021

author name string

David J Harman

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28404158%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Guruprasad P Aithal

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28404158%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

publication date

1 February 2017

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28404158%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

The lancet. Gastroenterology & hepatology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28404158%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28404158%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28404158%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

288-297

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28404158%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015.

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930205-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930205-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Liver cirrhosis mortality rates in Britain from 1950 to 2002: an analysis of routine data

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930205-9

7 January 2021

based on heuristic

inferred from DOI database lookup

How to tackle rising rates of liver disease in the UK

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930205-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The burden of liver disease in Europe: a review of available epidemiological data

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930205-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Implementation of the Lancet Standing Commission on Liver Disease in the UK.

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930205-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Screening for liver fibrosis in the general population: a call for action.

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930205-9

7 January 2021

based on heuristic

inferred from DOI database lookup

1 and 5 year survival estimates for people with cirrhosis of the liver in England, 1998-2009: a large population study

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930205-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Health outcomes following liver function testing in primary care: a retrospective cohort study.

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930205-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930205-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Findings on liver biopsy to investigate abnormal liver function tests in the absence of diagnostic serology

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930205-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930205-9

7 January 2021

based on heuristic

inferred from DOI database lookup

EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930205-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Performance of transient elastography for the staging of liver fibrosis: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930205-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930205-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease.

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930205-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930205-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Discrimination of individuals in a general population at high-risk for alcoholic and non-alcoholic fatty liver disease based on liver stiffness: a cross section study

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930205-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: a population study using proton-magnetic resonance spectroscopy and transient elastography

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930205-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Factors associated with significant liver fibrosis assessed using transient elastography in general population.

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930205-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Food intake increases liver stiffness measurements and hampers reliable values in patients with chronic hepatitis B and healthy controls: the PROLIFICA experience in The Gambia.

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930205-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Using transient elastography to detect chronic liver diseases in a primary care nurse consultancy.

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930205-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The association between adipocytokines and biomarkers for nonalcoholic fatty liver disease-induced liver injury: a study in the general population

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930205-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevalence of liver fibrosis and risk factors in a general population using non-invasive biomarkers (FibroTest)

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930205-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Transient elastography as a screening tool for liver fibrosis and cirrhosis in a community-based population aged over 45 years

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930205-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Presence and severity of non-alcoholic fatty liver disease in a large prospective primary care cohort.

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930205-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930205-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevalence and markers of advanced liver disease in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930205-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Using non-invasive biomarkers to identify hepatic fibrosis in people with type 2 diabetes mellitus: the Edinburgh type 2 diabetes study.

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930205-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonobese population in a developing country has a high prevalence of nonalcoholic fatty liver and significant liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930205-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Feasibility of detection and intervention for alcohol-related liver disease in the community: the Alcohol and Liver Disease Detection study (ALDDeS).

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930205-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Outreach screening of drug users for cirrhosis with transient elastography.

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930205-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Direct targeting of risk factors significantly increases the detection of liver cirrhosis in primary care: a cross-sectional diagnostic study utilising transient elastography

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930205-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Assessment of asymptomatic liver fibrosis in alcoholic patients using fibroscan: prospective comparison with seven non-invasive laboratory tests.

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930205-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Assessment of liver fibrosis using transient elastography in patients with alcoholic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930205-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Updated definitions of healthy ranges for serum alanine aminotransferase levels

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930205-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Incidence and prevalence of cirrhosis in the United Kingdom, 1992–2001: A general population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930205-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Alcoholic cirrhosis in Denmark - population-based incidence, prevalence, and hospitalization rates between 1988 and 2005: a descriptive cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930205-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Liver stiffness values in apparently healthy subjects: influence of gender and metabolic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930205-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Transient elastography in healthy subjects and factors influencing liver stiffness in non-alcoholic fatty liver disease: An Italian community-based population study.

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930205-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Intra-laboratory analytical variability of biochemical markers of fibrosis (Fibrotest) and activity (Actitest) and reference ranges in healthy blood donors

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930205-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930205-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930205-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Sampling Variability of Liver Biopsy in Nonalcoholic Fatty Liver Disease

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930205-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Diagnostic accuracy and prognostic significance of blood fibrosis tests and liver stiffness measurement by FibroScan in non-alcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930205-9

7 January 2021

based on heuristic

inferred from DOI database lookup

EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2816%2930205-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S2468-1253(16)30205-9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28404158%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28404158%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30234829&oldid=1623488837"